(资料图)
Truist Securities将西维斯健康的目标价从95美元上调至98美元,维持“买入”评级。(格隆汇)
2025-12-11
2025-12-10
2025-12-09
2025-12-08
2025-12-07
2025-12-06
2025-12-05
2025-12-04
2025-12-03
2025-12-02
2025-12-01
2025-11-30
2025-11-29
2025-11-28